Contact Us

    Choose Type

    Recent Updates
    MicroQuant™: A Novel Approach to Microbial Quality Control
    09 Mar 2025

    MicroQuant™: A Novel Approach to Microbial Quality Control

    MicroQuant™ by ATCC sets a new standard in microbial quality control, providing pre-quantified CFU pellets for precise and reproducible laboratory testing.

    ATCC – the largest cell bank in the world: exclusive distribution by IMBH in Israel

    More Info About ATCC +

    Microbial quality control is a fundamental aspect of pharmaceutical manufacturing, as it ensures both product safety and compliance with regulatory standards. However, traditional approaches often suffer from inconsistencies in microbial quantification, which can lead to potential deviations in quality control assessments. To address these challenges, MicroQuant™, developed by ATCC, represents a breakthrough in microbial reference materials by providing pre-quantified, ready-to-use CFU (colony-forming unit) pellets that enhance precision and reproducibility in microbial testing. In this article, we explore the scientific rationale, technical specifications, and applications of MicroQuant™ in the context of pharmaceutical quality assurance.

    Ensuring the accuracy of microbial quality control testing is critical for pharmaceutical production and microbiology laboratories. However, conventional methods of microbial quantification are prone to batch-to-batch variability, requiring extensive preparation and handling that, in turn, increase the risk of procedural errors. Therefore, the development of MicroQuant™ provides a solution by offering a standardized, quantitated microbial reference material that not only improves laboratory efficiency but also reduces inconsistencies in microbial enumeration.

    Methodology and Technical Specifications

    1. Quantified Microbial Reference Standards

    MicroQuant™ utilizes highly precise CFU quantification techniques to deliver standardized microbial loads in a ready-to-use format. Available CFU concentrations include:

    • High concentration: 10⁷ – 10⁸ CFU per pellet
    • Low concentration: 100 – 1,000 CFU per pellet

    Each suitable for 10 tests per pellet

    These values align with USP General Chapter requirements, ensuring strict compliance with industry regulations.

    2. Single-Use Format for Improved Accuracy

    Each MicroQuant™ pellet is individually prepared to maintain consistency, thereby eliminating the need for labor-intensive preparation of microbial cultures. Additionally, the single-use format enhances procedural integrity and effectively prevents cross-contamination, which is a common issue in traditional microbial preparation techniques.

    3. Rapid Dissolution and Stability

    Unlike conventional microbial standards that require controlled incubation, MicroQuant™ pellets dissolve instantly at room temperature within one minute. Consequently, this feature significantly reduces testing turnaround times while simultaneously enhancing laboratory workflow efficiency. Moreover, the product remains stable under refrigerated conditions (2-8°C) for 6-12 months, ensuring both convenient storage and consistent availability.

    4. Compliance with ISO 17034 Standards

    MicroQuant™ is produced in adherence to ISO 17034-certified manufacturing processes, ensuring batch-to-batch consistency and reliability. This compliance not only supports the credibility of laboratory data but also reinforces the product’s utility in regulated environments such as pharmaceutical and clinical microbiology laboratories. Moreover, it ensures adherence to stringent industry standards, enhancing confidence in test reliability and reproducibility.

    Applications in Microbial Quality Control

    MicroQuant™ is widely applicable across multiple quality control methodologies. Specifically, it can be utilized for:

    • Growth promotion testing for culture media validation
    • Bioburden testing to assess microbial load in pharmaceutical products
    • Sterility testing to verify the absence of microbial contamination
    • Microbial limit testing in compliance with pharmacopoeial standards
    • Environmental monitoring to track microbial presence in controlled settings
    • Preservative efficacy testing to evaluate antimicrobial preservative effectiveness
    • Antimicrobial effectiveness testing in research and development of new formulations

    By integrating MicroQuant™ into microbial quality control workflows, laboratories can achieve greater reproducibility, accuracy, and regulatory compliance, reinforcing confidence in pharmaceutical safety and efficacy.

    MicroQuant™ represents a significant advancement in microbial reference materials, effectively addressing key challenges in quantitative microbiology. By eliminating preparation variability, reducing test complexity, and improving microbial enumeration precision, it not only supports pharmaceutical manufacturers and microbiologists in maintaining the highest standards of microbial quality control but also ensures consistency in testing methodologies. Furthermore, as regulatory demands continue to evolve, MicroQuant™ positions itself as an essential tool for modern microbiological testing, reinforcing compliance and reliability in laboratory workflows.

    Further Information

    To explore how MicroQuant™ can optimize your microbial testing procedures, visit the official ATCC product page.

    For more details or inquiries, contact us today!

    Contact Us

    Tel: 04-8689015
    Fax: 04-8689010
    Email: info@bemek.co.il
    Beit Haemek, Israel 2511500

      Choose Type

      IMBH - Import and Marketing Beit HaEmek, Israel.
      Distributor and supplier of ATCC, Promega, Promocell, Chemometec, Biowest, LSG, Reprocell, AnyGenes, ABClonal, CelVivo, Softgenetics, Filtrox, Quatroflow, Amazon Filters, Industrial Filters and Vectron.
      Biotechnology products for molecular biology, cell analysis, cell culture, genetic identification, microbiology, protein analysis, advanced filtration for the food and beverage market and unique filtration solutions for the pharmaceutical and biotechnology market.

      Accessibility Toolbar